---
title: "Top 5 CDRs Gainers/Losers (>100M) (6.10)"
description: "Quantasing(QSG) rose 32.95%, with a trading turnover 50.2 Million USD, and a year-to-date rose 327.8%. Yatsen(YSG) rose 15.68%, with a trading turnover 14.4 Million USD, and a year-to-date rose 105.8%"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/243961698.md"
published_at: "2025-06-10T22:00:53.000Z"
---

# Top 5 CDRs Gainers/Losers (>100M) (6.10)

> Quantasing(QSG) rose 32.95%, with a trading turnover 50.2 Million USD, and a year-to-date rose 327.8%. Yatsen(YSG) rose 15.68%, with a trading turnover 14.4 Million USD, and a year-to-date rose 105.8%. ECARX(ECX) fell 5.81%, with a trading turnover 1.4 Million USD, and a year-to-date fell 23.2%. I-Mab(IMAB) fell 5.71%, with a trading turnover 3.1 Million USD, and a year-to-date rose 210.6%.

NASDAQ Composite Index has rose 0.63%, with a year-to-date rose 2.1%; S&P 500 has rose 0.55%, with a year-to-date rose 2.7%; Dow Jones Industrial Average has rose 0.25%, with a year-to-date rose 0.8%.

Quantasing(QSG) rose 32.95%, with a trading turnover 50.2 Million USD, and a year-to-date rose 327.8%.

Yatsen(YSG) rose 15.68%, with a trading turnover 14.4 Million USD, and a year-to-date rose 105.8%.

ECARX(ECX) fell 5.81%, with a trading turnover 1.4 Million USD, and a year-to-date fell 23.2%.

I-Mab(IMAB) fell 5.71%, with a trading turnover 3.1 Million USD, and a year-to-date rose 210.6%.

### Related Stocks

- [QSG.US - Quantasing](https://longbridge.com/en/quote/QSG.US.md)
- [YSG.US - Yatsen](https://longbridge.com/en/quote/YSG.US.md)
- [COE.US - 51 Online Edu](https://longbridge.com/en/quote/COE.US.md)
- [NIO.US - NIO Inc](https://longbridge.com/en/quote/NIO.US.md)
- [ZLAB.US - Zai Lab](https://longbridge.com/en/quote/ZLAB.US.md)
- [ECX.US - ECARX](https://longbridge.com/en/quote/ECX.US.md)
- [IMAB.US - I-Mab](https://longbridge.com/en/quote/IMAB.US.md)
- [LX.US - LexinFintech](https://longbridge.com/en/quote/LX.US.md)
- [HSAI.US - Hesai](https://longbridge.com/en/quote/HSAI.US.md)
- [LI.US - Li Auto](https://longbridge.com/en/quote/LI.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| ECARX Holdings 财报回顾：第四季度总结 | ECARX Holdings（纳斯达克代码：ECX）于 2026 年 2 月 12 日公布了其第四季度财报，显示其每股收益（EPS）为-$0.02，超出预期的-$0.03，超出幅度为 33.33%。与去年相比，收入增加了 3880 万美元。 | [Link](https://longbridge.com/en/news/275757030.md) |
| 再鼎医药将于 2 月 26 日召开董事会会议，以批准并公布 2025 年度业绩 | 再鼎医药有限公司已安排于 2026 年 2 月 26 日召开董事会会议，以批准截至 2025 年 12 月 31 日的经审计财务结果，符合美国通用会计准则（U.S. GAAP）。如果获得批准，结果将在同一天发布，并随后举行投资者电话会议。公 | [Link](https://longbridge.com/en/news/275665019.md) |
| 在与禾赛达成独家激光雷达分销协议后，评估 Grab Holdings（纳斯达克 GS:GRAB）的估值 | Grab Holdings (GRAB) 被选为禾赛科技在东南亚激光雷达产品的独家分销商，进一步增强其在自动驾驶领域的专注。尽管最近股价有所上涨，但 Grab 的估值仍然是一个争论的话题，公允价值估计为 8.20 美元，而其当前价格为 4. | [Link](https://longbridge.com/en/news/275459363.md) |
| Grab Holdings Ltd.成为 Hesai 激光雷达在东南亚地区的独家销售伙伴 | Grab Holdings Ltd. 宣布与禾赛科技建立战略合作关系，成为禾赛激光雷达产品在东南亚的独家分销商。Grab 将负责该地区传感器的分销、客户支持和市场营销 | [Link](https://longbridge.com/en/news/275253142.md) |
| 浦发银行重申对再鼎医药有限公司（1ZLB）的买入评级 | 在昨天发布的一份报告中，浦发银行维持了对再鼎医药的买入评级，目标价为 20.00 港元。该公司股票上周五收盘价为 12.44 港元。获取 50% 折扣的 TipRanks Premium，解锁对冲基金级别的数据和强大的投资工具，以便做出更聪 | [Link](https://longbridge.com/en/news/274601457.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.